Trial Information
Summary: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Post-Marketing Non-Interventional Pharmacoepidemiology Study to Evaluate Long-Term Safety, Tolerability and Compliance in Administration of Xyrem ® (Sodium Oxybate) in Regular Clinical Practice
Patients will be followed up for max 18 months. Information on the adverse events and potential misuse or abuse of Xyrem ® will be collected
Inclusion Criteria:
Patient s who received Xyrem® on prescription
|
Contact:
UCB Clinical Trial Call Center
Located in:
Inssbruck, Austria,
Telephone: +1-877-822-9493
|
|

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: March 17, 2008 at 3:01:37 PM